| Cell line name |
43-9F |
|---|
| Accession |
CVCL_UF07 |
|---|
| Resource Identification Initiative |
To cite this cell line use: 43-9F (RRID:CVCL_UF07) |
|---|
| Comments |
Group: Patented cell line.
Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85061402.
Monoclonal antibody isotype: IgM.
Monoclonal antibody target: Beta-Gal(1->3)-[alpha-Fuc(1->4)]-beta-GlcNAc(1->3)-beta-Gal(1->4)[alpha-Fuc(1->3)]beta-GlcNAc(1->3)-R. |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
|---|
| Category |
Hybridoma |
|---|
| Publications | Patent=EP0184906A1
Lennart Olsson;
Monoclonal antibodies specific for human squamous lung carninoma cells, their preparation and use.
Patent number EP0184906A1, 18-Jun-1986 PubMed=2433033
David E. Pettijohn, Patricia L. Stranahan, Claus Due, Ebbe Ronne, Hans Rahbek Sorensen, Lennart Olsson;
Glycoproteins distinguishing non-small cell from small cell human lung carcinoma recognized by monoclonal antibody 43-9F.
Cancer Res. 47:1161-1169(1987) PubMed=2445477
Claus Due, Hakan Eriksson, Anne Sihm, Lennart Olsson;
Association between expression of a tumor-associated carbohydrate epitope and the proliferative and tumorigenic activity of a human squamous lung cancer cell line and epitope-positive and -negative sublines.
Cancer Res. 47:6697-6704(1987) PubMed=3422461; DOI=10.1073/pnas.85.3.802; PMCID=PMC279643
David E. Pettijohn, Oswald Pfenninger, Jerry Brown, Richard C. Duke, Lennart Olsson;
Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells.
Proc. Natl. Acad. Sci. U.S.A. 85:802-806(1988) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q93306930
|
|---|
| Entry history |
|---|
| Entry creation | 13-Nov-2018 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 4 |
|---|
